Biotech gainers were led by Zhengye Biotechnology, which surged as Nasdaq delisting concerns eased. Advanced Biomed also rose after withdrawing its planned U.S. securities offering and reducing potential dilution concerns.
Biotech gainers were led by Zhengye Biotechnology, which surged as Nasdaq delisting concerns eased. Advanced Biomed also rose after withdrawing its planned U.S. securities offering and reducing potential dilution concerns.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
